Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
The Prostate
|
February 19, 2000
Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation
M Marcelli, M Marani, X Li, et al.
The Journal of Urology
|
August 1, 1996
Androgen receptor gene mutations are rarely associated with isolated penile hypospadias
R W Sutherland, J S Wiener, J P Hicks, et al.
Endocrinology
|
March 17, 2001
Irradiation selectively inhibits expression from the androgen-dependent Pem homeobox gene promoter in sertoli cells
S Maiti, M L Meistrich, G Wilson, et al.
Cancer Research
|
February 2, 1999
Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer
M Marcelli, G R Cunningham, M Walkup, et al.
The Journal of Urology
|
May 23, 1998
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study
O Z Hampel, M W Kattan, G Yang, et al.
Child: Care, Health and Development
|
October 31, 2008
Health status of children with cerebral palsy living in Europe: a multi-centre study
E Beckung, M White-Koning, M Marcelli, et al.
Human Molecular Genetics
|
April 10, 1999
Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
D L Stenoien, C J Cummings, H P Adams, et al.
Journal of the National Cancer Institute
|
September 6, 2001
Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells
F Andriani, B Nan, J Yu, et al.
Cancer Research
|
March 8, 2000
Androgen receptor mutations in prostate cancer
M Marcelli, M Ittmann, S Mariani, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 22, 1999
A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)
L V Nazareth, D L Stenoien, W E Bingman, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
The Prostate
|
February 19, 2000
Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation
M Marcelli, M Marani, X Li, et al.
The Journal of Urology
|
August 1, 1996
Androgen receptor gene mutations are rarely associated with isolated penile hypospadias
R W Sutherland, J S Wiener, J P Hicks, et al.
Endocrinology
|
March 17, 2001
Irradiation selectively inhibits expression from the androgen-dependent Pem homeobox gene promoter in sertoli cells
S Maiti, M L Meistrich, G Wilson, et al.
Cancer Research
|
February 2, 1999
Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer
M Marcelli, G R Cunningham, M Walkup, et al.
The Journal of Urology
|
May 23, 1998
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study
O Z Hampel, M W Kattan, G Yang, et al.
Child: Care, Health and Development
|
October 31, 2008
Health status of children with cerebral palsy living in Europe: a multi-centre study
E Beckung, M White-Koning, M Marcelli, et al.
Human Molecular Genetics
|
April 10, 1999
Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
D L Stenoien, C J Cummings, H P Adams, et al.
Journal of the National Cancer Institute
|
September 6, 2001
Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells
F Andriani, B Nan, J Yu, et al.
Cancer Research
|
March 8, 2000
Androgen receptor mutations in prostate cancer
M Marcelli, M Ittmann, S Mariani, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 22, 1999
A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)
L V Nazareth, D L Stenoien, W E Bingman, et al.
Page
of 10